Is CRPS-1 a Chronic Disabling Disease? A Long-term, Real-Life Study on Patients Treated With Neridronate.

Clin Med Insights Arthritis Musculoskelet Disord · 2024 · PMC11542109 · PMID 39512444

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Both instruments employed to assess residual pain (VAS and McGill Pain questionnaire) showed highly significant decreases when compared with values observed before treatment ( Table 2 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.